60
Participants
Start Date
April 25, 2005
Primary Completion Date
May 30, 2005
Study Completion Date
May 30, 2005
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore
National Institute of Allergy and Infectious Diseases (NIAID)
NIH